Evoke Wealth, LLC Repligen Corp Transaction History

Evoke Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$114.17 - $185.35 $1.24 Million - $2.02 Million	10,873 New	10,873 $1.95 Million
Q1 2022 May 10, 2022	SELL	$161.19 - $257.96 $2,417 - $3,869	-15 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$165.87 - $220.95 $3,151 - $4,198	-19 Reduced 55.88%	15 $3,000
Q1 2021 May 13, 2021	BUY	$180.37 - $226.26 $6,132 - $7,692	34 New	34 $7,000

486

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.91B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.